Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025340200> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2025340200 endingPage "909" @default.
- W2025340200 startingPage "909" @default.
- W2025340200 abstract "Letters and Corrections1 June 1987Bromocriptine Therapy and HyperprolactinemiaJOSÉ M. LÓPEZ, M.D., CARLOS B. FARDELLA, M.D.JOSÉ M. LÓPEZ, M.D.Search for more papers by this author, CARLOS B. FARDELLA, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-106-6-909_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Bromocriptine, acting as a dopaminergic agonist, reduces the secretion of prolactin by the pituitary gland (1) and can also reduce the size of prolactinomas through a reduction of cytoplasmatic cell volume and tumoral cell population (2, 3). The usual dose of bromocriptine as a treatment for prolactinomas is from 5.0 to 10.0 mg/24 h. We report the case of a man with a prolactinoma who drastically reduced his serum prolactin level when treated with minimal doses of bromocriptine.A 55-year-old man was seen in December 1983 because of lack of libido, but was otherwise asymptomatic. His serum...References1. VANCEEVANSTHORNER MWM. Bromocriptine. Ann Intern Med. 1984;100:78-91. LinkGoogle Scholar2. INDALLKOVACSHORVATHTHORNER GKEM. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural and morphometric study. J Clin Endocrinol Metab. 1982;55:1178-83. CrossrefMedlineGoogle Scholar3. GENUOZUMIOHTAITOKAJIWARAMORI MTMAHS. Necrotic changes in prolactinomas after long term administration of bromocriptine. J Clin Endocrinol Metab. 1984;59:463-70. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Universidad Católica de Chile Casilla 114-D; Santiago Chile PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byReversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists 1 June 1987Volume 106, Issue 6Page: 909-910KeywordsDopaminergicsPituitary glandProlactin Issue Published: 1 June 1987 PDF downloadLoading ..." @default.
- W2025340200 created "2016-06-24" @default.
- W2025340200 creator A5009869626 @default.
- W2025340200 date "1987-06-01" @default.
- W2025340200 modified "2023-09-24" @default.
- W2025340200 title "Bromocriptine Therapy and Hyperprolactinemia" @default.
- W2025340200 cites W1987413422 @default.
- W2025340200 cites W2088735547 @default.
- W2025340200 cites W2097313178 @default.
- W2025340200 doi "https://doi.org/10.7326/0003-4819-106-6-909_2" @default.
- W2025340200 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3579079" @default.
- W2025340200 hasPublicationYear "1987" @default.
- W2025340200 type Work @default.
- W2025340200 sameAs 2025340200 @default.
- W2025340200 citedByCount "1" @default.
- W2025340200 crossrefType "journal-article" @default.
- W2025340200 hasAuthorship W2025340200A5009869626 @default.
- W2025340200 hasConcept C126322002 @default.
- W2025340200 hasConcept C134018914 @default.
- W2025340200 hasConcept C137183658 @default.
- W2025340200 hasConcept C2776856834 @default.
- W2025340200 hasConcept C2777658017 @default.
- W2025340200 hasConcept C2777910003 @default.
- W2025340200 hasConcept C2778258207 @default.
- W2025340200 hasConcept C2778918492 @default.
- W2025340200 hasConcept C2779064019 @default.
- W2025340200 hasConcept C2908647359 @default.
- W2025340200 hasConcept C2908910360 @default.
- W2025340200 hasConcept C513476851 @default.
- W2025340200 hasConcept C71315377 @default.
- W2025340200 hasConcept C71924100 @default.
- W2025340200 hasConcept C90924648 @default.
- W2025340200 hasConcept C99454951 @default.
- W2025340200 hasConceptScore W2025340200C126322002 @default.
- W2025340200 hasConceptScore W2025340200C134018914 @default.
- W2025340200 hasConceptScore W2025340200C137183658 @default.
- W2025340200 hasConceptScore W2025340200C2776856834 @default.
- W2025340200 hasConceptScore W2025340200C2777658017 @default.
- W2025340200 hasConceptScore W2025340200C2777910003 @default.
- W2025340200 hasConceptScore W2025340200C2778258207 @default.
- W2025340200 hasConceptScore W2025340200C2778918492 @default.
- W2025340200 hasConceptScore W2025340200C2779064019 @default.
- W2025340200 hasConceptScore W2025340200C2908647359 @default.
- W2025340200 hasConceptScore W2025340200C2908910360 @default.
- W2025340200 hasConceptScore W2025340200C513476851 @default.
- W2025340200 hasConceptScore W2025340200C71315377 @default.
- W2025340200 hasConceptScore W2025340200C71924100 @default.
- W2025340200 hasConceptScore W2025340200C90924648 @default.
- W2025340200 hasConceptScore W2025340200C99454951 @default.
- W2025340200 hasIssue "6" @default.
- W2025340200 hasLocation W20253402001 @default.
- W2025340200 hasLocation W20253402002 @default.
- W2025340200 hasOpenAccess W2025340200 @default.
- W2025340200 hasPrimaryLocation W20253402001 @default.
- W2025340200 hasRelatedWork W1983836497 @default.
- W2025340200 hasRelatedWork W1985786391 @default.
- W2025340200 hasRelatedWork W2000833909 @default.
- W2025340200 hasRelatedWork W2027099120 @default.
- W2025340200 hasRelatedWork W2027596383 @default.
- W2025340200 hasRelatedWork W2030770178 @default.
- W2025340200 hasRelatedWork W2057799013 @default.
- W2025340200 hasRelatedWork W2105916581 @default.
- W2025340200 hasRelatedWork W2106565221 @default.
- W2025340200 hasRelatedWork W2469936039 @default.
- W2025340200 hasVolume "106" @default.
- W2025340200 isParatext "false" @default.
- W2025340200 isRetracted "false" @default.
- W2025340200 magId "2025340200" @default.
- W2025340200 workType "article" @default.